Delivery Order SPE2DB22D9311-SPE2DB25FP6XU

Award Date 3/4/25
Potential Completion Date 3/5/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $2,373.04 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of M-M-R II vaccine vials to support the medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with a completion date of February 28, 2025. DMS Pharmaceutical Group Inc. also holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,133.72 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a performance period through August 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $11,337 contract is for the delivery of M-M-R II vaccine vials, with a completion date of March 5, 2024. The contract is issued under DMS Pharmaceutical Group's indefinite delivery contract 4600082013 with the DLA, valued at up to $4,999,999 through 2025. This single-award vehicle allows...
This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,203.30 contract is for the delivery of M-M-R II vaccine vials, with a completion date of August 7, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $11,865.20, is for the delivery of M-M-R II vaccine vials to support the medical supply needs of military healthcare facilities. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This federal contract award, with ID SPE2DB22D9311|SPE2DB25FP6XF, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,339.25 firm fixed-price delivery order is for the provision of M-M-R II vaccine vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,186.52, is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials. The award is not associated with a set-aside designation. It represents one of several federal contract awards received by DMS Pharmaceutical Group, which holds a significant...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $1,592.67 under an indefinite delivery contract with the Defense Logistics Agency to supply measles, mumps and rubella vaccines. The delivery order was awarded on November 24, 2021 with a completion date of December 9, 2021. No set-aside designation was used for this award. DMS Pharmaceutical Group will supply the vaccines to Defense Logistics Agency Troop Support Medical facilities located in Park Ridge,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the YF-VAX 1 dose vaccine vials and has a completion date of November 30, 2021. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,806.76 contract is for the delivery of VARIVAX vaccine with diluents to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
  • SPE2DB22D9311
    Indefinite Delivery Contract
  • SPE2DB22D9311-SPE2DB25FP6XU
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $4,152.75 and covers the delivery of M-M-R II vaccine vials to support the medical supply needs of military healthcare facilities.

DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense (DoD). The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the DLA to issue firm fixed-price delivery orders for a wide variety of pharmaceutical products to support military health facilities worldwide.

This particular contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 6/3/25, 9:51 AM